Heart failure with tyrosine kinase-targeting drugs

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-017-29289-3
中图分类号
学科分类号
摘要
引用
收藏
页码:10 / 10
相关论文
共 50 条
  • [1] Tyrosine kinase-targeting drugs-associated heart failure
    Gronich, N.
    Lavi, I.
    Barnett-Griness, O.
    Saliba, W.
    Abernethy, D. R.
    Rennert, G.
    BRITISH JOURNAL OF CANCER, 2017, 116 (10) : 1366 - 1373
  • [2] Tyrosine kinase-targeting drugs-associated heart failure
    N Gronich
    I Lavi
    O Barnett-Griness
    W Saliba
    D R Abernethy
    G Rennert
    British Journal of Cancer, 2017, 116 : 1366 - 1373
  • [3] Empowering host immunity by kinase-targeting in LSC
    Wang, Qian-Fei
    BLOOD SCIENCE, 2020, 2 (03): : 107 - 108
  • [4] Pharmacogenetic targeting of drugs for heart failure
    Bristow, Michael R.
    PHARMACOLOGY & THERAPEUTICS, 2012, 134 (01) : 107 - 115
  • [5] TYROSINE KINASE TARGETING DRUGS-ASSOCIATED CONGESTIVE HEART FAILURE: TRASTUZUMAB, CETUXIMAB, PANITUMUMAB AND SUNITINIB ARE ASSOCIATED WITH INCREASED RISK.
    Gronich, N.
    Lavi, I.
    Barnett, O.
    Abernethy, D. R.
    Rennert, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S99 - S99
  • [6] Carbazole Derivatives as Kinase-Targeting Inhibitors for Cancer Treatment
    Ceramella, Jessica
    Iacopetta, Domenico
    Barbarossa, Alexia
    Caruso, Anna
    Grande, Fedora
    Bonomo, Maria Grazia
    Mariconda, Annaluisa
    Longo, Pasquale
    Carmela, Saturnino
    Sinicropi, Maria Stefania
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (06) : 444 - 465
  • [7] Synthesis and biological evaluation of p38α kinase-targeting dialkynylimidazoles
    Li, Jing
    Kaoud, Tamer S.
    Laroche, Christophe
    Dalby, Kevin N.
    Kerwin, Sean M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (22) : 6293 - 6297
  • [8] Tyrosine kinase-inhibitors and heart failure risk
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (06): : E302 - E302
  • [9] Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules
    Goebel, Georg L.
    Qiu, Xiaqiu
    Wu, Peng
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (10) : 866 - 881
  • [10] Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
    Tanaka, Yoshiya
    Luo, Yiming
    O'Shea, John J.
    Nakayamada, Shingo
    NATURE REVIEWS RHEUMATOLOGY, 2022, 18 (03) : 133 - 145